SynthesisHead & face medicine2025

Unveiling the efficacy and safety of Erenumab, a monoclonal antibody targeting calcitonin gene-related peptide (CGRP) receptor, in patients with chronic and episodic migraine: a GRADE-assessed systematic review and meta-analysis of randomized clinical trials with subgroup analysis.

Mohamed E Haseeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.